PRECLINICAL & PHASE I STUDY OF TIRAPAZAMINE (SR 4233), A NOVEL HYPOXIC CELL CYTOTOXIN
Ph.D
Saved in:
Main Author: | SURESH SENAN |
---|---|
Other Authors: | DEPT OF PHARMACOLOGY |
Format: | Theses and Dissertations |
Published: |
2020
|
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/178519 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Cytotoxin and hemolysin in diseased fish during epidemic outbreaks
by: Laddavan Laohaviranit
Published: (2018) -
Helicobacter pylori vacuolating cytotoxin and gastric cancer risk: Reconsidered
by: Muhammad Miftahussurur, Muhammad Miftahussurur, et al.
Published: (2016) -
Helicobacter pylori vacuolating cytotoxin and gastric cancer risk: reconsidered
by: Muhammad Miftahussurur, et al.
Published: (2016) -
Cell based diabetes treatment in a preclinical model
by: WONG JEN SAN
Published: (2010) -
Protective effects of novel single compound, Hirsutine on hypoxic neonatal rat cardiomyocytes
by: Wu, L.X., et al.
Published: (2016)